Home › Compare › SLDX vs FCPT

SLDX vs FCPT: Dividend Comparison 2026

SLDX yields 12500.00% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SLDX wins by $498747976996367872.00M in total portfolio value
10 years
SLDX
SLDX
● Live price
12500.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$498747976996367872.00M
Annual income
$491,020,681,003,619,800,000,000.00
Full SLDX calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — SLDX vs FCPT

📍 SLDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLDXFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLDX + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SLDX pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLDX
Annual income on $10K today (after 15% tax)
$1,062,500.00/yr
After 10yr DRIP, annual income (after tax)
$417,367,578,853,076,800,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, SLDX beats the other by $417,367,578,853,076,800,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLDX + FCPT for your $10,000?

SLDX: 50%FCPT: 50%
100% FCPT50/50100% SLDX
Portfolio after 10yr
$249373988498183936.00M
Annual income
$245,510,340,501,809,900,000,000.00/yr
Blended yield
98.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

SLDX
No analyst data
Altman Z
-984.6
Piotroski
5/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLDX buys
0
FCPT buys
0
No recent congressional trades found for SLDX or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLDXFCPT
Forward yield12500.00% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$498747976996367872.00M ✓$49.1K
Annual income after 10y$491,020,681,003,619,800,000,000.00 ✓$5,775.28
Total dividends collected$498235517183739840.00M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SLDX vs FCPT ($10,000, DRIP)

YearSLDX PortfolioSLDX Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$1,260,700$1,250,000.00$11,401$700.92+$1.25M → SLDX
2$148,626,986$147,278,037.38$13,064$864.84+$148.61M → SLDX
3$16,386,101,622$16,227,070,746.70$15,051$1,072.48+$16386.09M → SLDX
4$1,689,525,624,319$1,671,992,495,582.84$17,442$1,337.22+$1689525.61M → SLDX
5$162,924,168,596,046$161,116,376,178,025.50$20,340$1,677.08+$162924168.58M → SLDX
6$14,694,663,924,503,782$14,520,335,064,106,012.00$23,880$2,116.57+$14694663924.48M → SLDX
7$1,239,682,670,110,485,000$1,223,959,379,711,266,000.00$28,241$2,689.36+$1239682670110.46M → SLDX
8$97,827,968,310,781,350,000$96,501,507,853,763,130,000.00$33,660$3,442.07+$97827968310781.31M → SLDX
9$7,221,771,955,839,384,000,000$7,117,096,029,746,848,000,000.00$40,456$4,439.95+$7221771955839384.00M → SLDX
10$498,747,976,996,367,840,000,000$491,020,681,003,619,800,000,000.00$49,063$5,775.28+$498747976996367872.00M → SLDX

SLDX vs FCPT: Complete Analysis 2026

SLDX — Stock

Stella Diagnostics, Inc., a molecular diagnostics-based company, focuses on enhancing patient management strategies for people living with severe esophageal diseases. Its clinical assays offer physicians insight into the molecular properties of patients' tissue to determine if the disease is stable, progressing, or turning cancerous. The company is also developing diagnostic tools that provides molecular information for providers as compared to the screening protocols. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in April 2021. Stella Diagnostics, Inc. is based in Salt Lake City, Utah.

Full SLDX Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this SLDX vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLDX vs SCHDSLDX vs JEPISLDX vs OSLDX vs KOSLDX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.